메뉴 건너뛰기




Volumn 18, Issue 3, 2008, Pages 225-226

Failure of omalizumab treatment after recurrent systemic reactions to bee-venom immunotherapy

Author keywords

Anaphylactic reaction; Bee venom; Immunotherapy; Omalizumab

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; BEE VENOM; IMMUNOGLOBULIN E; OMALIZUMAB;

EID: 45749144691     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (41)

References (5)
  • 1
    • 27844541751 scopus 로고    scopus 로고
    • Prevention and treatment of hymenoptera venom allergy: Guidelines for clinical practice
    • Bonifazi F, Jutel M, Bilo BM, Birnbaum J, Muller U. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy. 2005;60:1459-70.
    • (2005) Allergy , vol.60 , pp. 1459-1470
    • Bonifazi, F.1    Jutel, M.2    Bilo, B.M.3    Birnbaum, J.4    Muller, U.5
  • 3
    • 26444539461 scopus 로고    scopus 로고
    • Omalizumab, other indications and unanswered questions
    • Vaishali S, Mankad A, Burks W. Omalizumab, other indications and unanswered questions. Clin Rev Allergy Immunol. 2005;29:17-30.
    • (2005) Clin Rev Allergy Immunol , vol.29 , pp. 17-30
    • Vaishali, S.1    Mankad, A.2    Burks, W.3
  • 4
    • 34447125094 scopus 로고    scopus 로고
    • Beekeepers anaphylaxis: Successful immunotherapy covered by omalizumab
    • Schulze J, Rose M, Zielen S. Beekeepers anaphylaxis: successful immunotherapy covered by omalizumab. Allergy. 2007;62:963-4.
    • (2007) Allergy , vol.62 , pp. 963-964
    • Schulze, J.1    Rose, M.2    Zielen, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.